Article Type
Changed
Fri, 04/26/2019 - 10:15
Display Headline
Troglitazone: A new antihyperglycemic agent
Article PDF
Author and Disclosure Information

Rex A. Speerhas, RPH
Mr. Speerhas is a board-certified nutrition support pharmacist and a certified diabetes educator at the Cleveland Clinic.

S. Sethu K. Reddy, MD, FRCPC
Dr. Reddy is a member of the staff of the Department of Endocrinology at the Cleveland Clinic and has research interests in the epidemiology of diabetes its risk factors, and the implementation of guidelines.

Issue
Cleveland Clinic Journal of Medicine - 64(5)
Publications
Page Number
238-240
Sections
Author and Disclosure Information

Rex A. Speerhas, RPH
Mr. Speerhas is a board-certified nutrition support pharmacist and a certified diabetes educator at the Cleveland Clinic.

S. Sethu K. Reddy, MD, FRCPC
Dr. Reddy is a member of the staff of the Department of Endocrinology at the Cleveland Clinic and has research interests in the epidemiology of diabetes its risk factors, and the implementation of guidelines.

Author and Disclosure Information

Rex A. Speerhas, RPH
Mr. Speerhas is a board-certified nutrition support pharmacist and a certified diabetes educator at the Cleveland Clinic.

S. Sethu K. Reddy, MD, FRCPC
Dr. Reddy is a member of the staff of the Department of Endocrinology at the Cleveland Clinic and has research interests in the epidemiology of diabetes its risk factors, and the implementation of guidelines.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 64(5)
Issue
Cleveland Clinic Journal of Medicine - 64(5)
Page Number
238-240
Page Number
238-240
Publications
Publications
Article Type
Display Headline
Troglitazone: A new antihyperglycemic agent
Display Headline
Troglitazone: A new antihyperglycemic agent
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media